CRL Financial Facts
Net sales related to products: 132.87MOperating income: 58.8M
See Full Income Statement
See Full Balance Sheet
Charles River Laboratories International, Inc. (CRL) Earnings
|
Expand Research on CRL
| Next EPS Date | 8/6/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +10.6% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +4.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/7/26  |
Q126 | N/A | $1.94 | N/A | N/A | $980.66M | = | N/A | N/A | ||
| 2/18/26 | Q425 | $2.39 | $2.35 | +$0.04 | $994.2M | $987.2M | = |  | | Details | |
| 11/5/25 | Q325 | $2.43 | $2.34 | +$0.09 | $1B | $987.43M | = | | | Details | |
| 8/6/25 | Q225 | $3.12 | $2.50 | +$0.62 | $1.03B | $984.86M | = | | | Details | |
| 5/7/25 | Q125 | $2.34 | $2.09 | +$0.25 | $984.2M | $941.47M | = | | | Details | |
| 2/19/25 | Q424 | $2.66 | $2.54 | +$0.12 | $1B | $985.18M | = | | | Details | |
| 11/6/24 | Q324 | $2.59 | $2.42 | +$0.17 | $1.01B | $976M | = | | | Details | |
| 8/7/24 | Q224 | $2.80 | $2.40 | +$0.40 | $1.03B | $1.02B | = | | | Details |
